SPAC Overview
Timeline Progress
About
TCGX Acquisition Corp. II is a blank-check company seeking an initial business combination, with a focus on healthcare, life sciences and medical technology companies. Its search may include Asia and China, with China-sourced assets expected to be a primary focus.
Investment Focus
Healthcare, Biopharmaceuticals, Technology
Geographic Focus
Asia, China
The terms and the filing trail behind TCGX Acquisition Corp. II
What the sponsor registered, what the deal actually priced at, and every 8-K that moved it — unit structure, sponsor promote, and the dated lifecycle events, each linked to its filing.
- Unit structure as registered and as priced — price, warrant coverage, rights, trust per unit
- Sponsor promote: founder shares and percentage, private-placement warrants, trust deposit
- The full 8-K lifecycle timeline, each event linked to its filing
- Price history across the unit, share and warrant tickers
- Follow it, and see it change on your watchlist
SPAC Team
Sponsors
Leadership
Underwriters
Extended Team Information
The team is led by Chen Yu, founder of TCGX and an experienced healthcare investor and operator, and Craig Skaling, an experienced finance and alternative-asset-management executive. Its independent director nominees bring biotechnology company-building, drug-development, healthcare operating and investment experience.